Federal (United States) · Regulations
Subpart A
14 sections
14 sections
- 21 C.F.R. § 201.1Drugs; name and place of business of manufacturer, packer, or distributor.
- 21 C.F.R. § 201.2Drugs and devices; National Drug Code numbers.
- 21 C.F.R. § 201.5Drugs; adequate directions for use.
- 21 C.F.R. § 201.6Drugs; misleading statements.
- 21 C.F.R. § 201.10Drugs; statement of ingredients.
- 21 C.F.R. § 201.15Drugs; prominence of required label statements.
- 21 C.F.R. § 201.16Drugs; Spanish-language version of certain required statements.
- 21 C.F.R. § 201.17Drugs; location of expiration date.
- 21 C.F.R. § 201.18Drugs; significance of control numbers.
- 21 C.F.R. § 201.19Drugs; use of term “infant”.
- 21 C.F.R. § 201.21Declaration of presence of phenylalanine as a component of aspartame in over-the-counter and prescription drugs for human use.
- 21 C.F.R. § 201.23Required pediatric studies.
- 21 C.F.R. § 201.24Labeling for systemic antibacterial drug products.
- 21 C.F.R. § 201.26Exceptions or alternatives to labeling requirements for human drug products held by the Strategic National Stockpile.